Compare Voyageur Pharmaceuticals Ltd. with Similar Stocks
Stock DNA
Chemicals & Petrochemicals
CAD 27 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.63
-121.86%
18.57
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Aug 2025)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.15%
0%
-15.15%
6 Months
-9.68%
0%
-9.68%
1 Year
-6.67%
0%
-6.67%
2 Years
100.0%
0%
100.0%
3 Years
86.67%
0%
86.67%
4 Years
27.27%
0%
27.27%
5 Years
-28.21%
0%
-28.21%
Voyageur Pharmaceuticals Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-0.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
18.57
EV to EBIT
-15.23
EV to EBITDA
-15.25
EV to Capital Employed
25.88
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-169.93%
ROE (Latest)
-121.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Aug'25 - YoY
Aug'25
Aug'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.30
-0.40
-225.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.30
-0.40
-225.00%
Operating Profit Margin (Excl OI)
-118,188.10%
0.00%
-11,818.81%
USD in Million.
Net Sales
YoY Growth in quarter ended Aug 2025 is 0.00% vs 0.00% in Aug 2024
Consolidated Net Profit
YoY Growth in quarter ended Aug 2025 is -225.00% vs -300.00% in Aug 2024
Annual Results Snapshot (Consolidated) - Nov'24
Nov'24
Nov'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.70
-1.30
-30.77%
Interest
0.00
0.00
Exceptional Items
-0.00
-0.10
100.00%
Consolidate Net Profit
-1.70
-1.40
-21.43%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Nov 2024 is 0.00% vs 0.00% in Nov 2023
Consolidated Net Profit
YoY Growth in year ended Nov 2024 is -21.43% vs 22.22% in Nov 2023
About Voyageur Pharmaceuticals Ltd. 
Voyageur Pharmaceuticals Ltd.
Chemicals & Petrochemicals
Voyageur Pharmaceuticals Ltd., formerly Voyageur Minerals Ltd., is an exploration stage pharmaceutical company. The Company is focused on manufacturing mineral based pharmaceutical products. The Company is engaged in the acquisition, exploration and evaluation of pharmaceutical mineral resource properties. It has interests in five mineral properties located in the province of British Colombia, Canada and the state of Utah, United States of America.
Company Coordinates 
Company Details
Suite 255, 339 50th Avenue SE , CALGARY AB : T2G 2B3
Registrar Details






